Duluth, Ga., Oct. 9, 2019 – Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76 million investment in its site in Athens, Ga. The investment doubled the company’s capacity to produce vaccines for pets in the United States and around the world.

2024年10月24日 · Boehringer Ingelheim's expanded Athens facility represents the company’s largest R&D site in the U.S. and its third largest globally. This sustainably focused facility houses the company’s U.S. Global Innovation Hub.

2022年4月26日 · Pharmaceutical company Boehringer Ingelheim is set to invest $57 million to expand its Animal Health Global Innovation center in Athens. The expansion was announced by Gov. Brian Kemp on April 20...

Atlanta, GA – April 20, 2022 – Governor Brian P. Kemp today announced that Boehringer Ingelheim, a global research-driven pharmaceutical development and manufacturing company based in Germany, will expand its Animal Health Global Innovation center in Athens, Georgia.

2022年4月22日 · Boehringer Ingelheim’s Animal Health business is growing its Global Innovation capabilities with a $57 million investment in new and expanded facilities at the company’s Athens, Georgia site.

DULUTH, Ga., Oct. 9, 2019 /PRNewswire/ -- Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76...

2024年10月30日 · Boehringer Ingelheim shared earlier this month that it has officially opened the expansion of its research and development facility in Athens, Georgia. This expansion was created with a capital investment of $66.1 million and …

2022年4月20日 · Atlanta, GA – Governor Brian P. Kemp today announced that Boehringer Ingelheim, a global research-driven pharmaceutical development and manufacturing company based in Germany, will expand its Animal Health Global Innovation center in Athens, Georgia.

2024年10月24日 · With a capital investment of $66.1 million and 63 new jobs created, this expansion includes the addition of 63,000 square feet of administrative space and over 28,000 square feet of laboratory...

Governor Brian P. Kemp announced on April 20, 2022 that Boehringer Ingelheim, a global research-driven pharmaceutical development and manufacturing company based in Germany, will expand its Animal Health Global Innovation center in Athens, Georgia.